Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review

International Journal of Hyperthermia

Volumn 29, Issue 8, 2013, Pages 801-809

  Alphandéry, Edouard ^a,b   Chebbi, Imène ^a   Guyot, François ^b   Durand Dubief, Mickaël ^a  

^a Nanobacterie SARL   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

Heat targeted drug delivery (i.e. nanoparticles; Liposomes; Magnetic hyperthermia; Magnetosome; Magnetotactic bacteria; Monoclonal antibodies)

Indexed keywords

NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ACUTE TOXICITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL MAGNETOSOME; BACTERIUM CULTURE; CANCER THERAPY; CELL ISOLATION; CELL SUSPENSION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FENTON REACTION; HEAT TREATMENT; HYPERTHERMIC THERAPY; IMMUNOTOXICITY; LOW DRUG DOSE; MAGNETOSOME; MAGNETOTHERAPY; NEOPLASM; NONHUMAN; PURIFICATION; REVIEW; RISK BENEFIT ANALYSIS;

ANIMALS; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC PHENOMENA; MAGNETOSOMES; NEOPLASMS;

EID: 84887969573     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.821527     Document Type: Review

References (44)

1. Jordan A, Scholz R, Maier-Hauff K, Van Landeghem FK, Waldoedner N, Teichgraeber U, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 2006;78:7-14. (Pubitemid 43786652)
2. Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003;94:308-13. (Pubitemid 36575900)
3. Zhao Q, Wang L, Cheng R, Mao L, Arnold RD, Howerth EW, et al. Magnetic nanoparticle-based hyperthermia for head and neck cancer in mouse models. Theranostics 2012;2:113-21.
4. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 2011;103:317-24.
5. Bazylinski DA, Frankel RB. Magnetosome formation in prokaryotes. Nature Rev Microbiol 2004;2:217-30. (Pubitemid 39496780)
6. Alphandéry E, Faure S, Seksek O, Guyot F, Chebbi I. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano 2011;5:6279-96.
7. Alphandéry E, Guyot F, Chebbi I. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia. Int J Pharm 2012;434: 444-52.
8. Sun J-B, Zhao F, Tang T, Jiang W, Tian J-S, Li J-L. High-yield growth and magnetosome formation by Magnetospirillum gryphiswaldense MSR-1 in an oxygen-controlled fermentor supplied solely with air. Appl Microbiol Biotechnol 2008;79:389-97.
9. Liu Y, Li GR, Jiang W, Li Y, Li LJ. Large-scale production of magnetosomes by chemostat culture of Magnetospirillum gryphiswaldense at high cell density. Microb Cell Fact 2010;9:99.
10. Zhang Y, Zhang X, Jiang W, Li Y, Li J. Semicontinuous culture of Magnetospirillum gryphiswaldense MSR-1 cells in an autofermentor by nutrient-balanced and isosmotic feeding strategies. Appl Environ Microbiol 2011;77:5851-6.
11. Heyen U, Schüler D. Growth and magnetosome formation by microaerophilic Magnetospirillum strains in an oxygen-controlled fermentor. Appl Microbiol Biotechnol 2003;61:536-44. (Pubitemid 36751018)
12. Matsunaga T, Tadokoro F, Nakamura N. Mass culture of magnetic bacteria and their application to flow type immunoassays. IEEE Trans Magn 1990;26:1557-9.
13. Matsunaga T, Tsujimura N, Kamiya S. Enhancement of magnetic particle production by nitrate and succinate fed-batched culture of Magnetospirillum sp. AMB-1. Biotechnol Tech 1996;10:495-500.
14. Yang C-D, Takeyama H, Tanaka T, Matsunaga T. Effects of growth medium composition, iron sources and atmospheric oxygen concentrations on production of luciferase-bacterial magnetic particle complex by a recombinant Magnetospirillum magneticum AMB-1. Enzyme Microbila Technol 2001;29:13-19. (Pubitemid 32566380)
15. Alphandéry E, Amor M, Guyot F, Chebbi I. The effects of ironchelating agents on Magnetospirillum magneticum strain AMB-1: Stimulated growth and magnetosome production and improved magnetosome heating properties. Appl Micriobiol Biotechnol 2012;96:663-70.
16. Philipse AP, Maas D. Magnetic colloids from magnetotactic bacteria: Chain formation and colloidal stability. Langmuir 2002; 18:9977-84.
17. Sun J-B, Duan J-H, Dai S-L, Ren J, Guo L, Jiang W, Li Y. Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense. Biotechnol Bioeng 2008;101:1313-20.
18. Taoka A, Asada R, Sasaki H, Anzawa K, Wu LF, Fukumori Y. Spatial localizations of Mam22 and Mam12 in the magnetosomes of Magnetospirillum magnetotacticum. J Bacteriol 2006;188: 3805-12. (Pubitemid 43825386)
19. Matsunaga T, Maeda Y, Yoshino T, Takeyama H, Takahashi M, Ginya H, et al. Fully automated immunoassay for detection of prostate-specific antigen nano-magnetic beads and micro-polystyrene bead composites, 'Beads on Beads'. Anal Chim Acta 2007;597: 331-9. (Pubitemid 47187819)
20. Grünberg K, Müller E-C, Otto A, Reska R, Linder D, Kube M, et al. Biochemical and proteomic analysis of the magnetosome membrane in Magnetospirillum gryphiswaldense. Appl Environ Microbiol 2004;70:1040-50. (Pubitemid 38578377)
21. Xiang L, Wei J, Jianbo S, Gulli W, Feng G, Ying L. Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in vitro. Lett Appl Microbiol 2007;45:75-81. (Pubitemid 47012107)
22. Guo F, Liu Y, Chen Y, Tang T, Jiang W, Li Y, Li J. A novel rapid and continuous procedure for large-scale purification of magnetosomes from Magnetospirillum gryphiswaldense. Appl Microbiol Biotechnol 2011;90:1277-83.
23. Tang T, Zhang L, Gao R, Dai Y, Meng F, Li Y. Fluorescence imaging and targeted distribution of bacterial magnetic particles in nude mice. Appl Microbiol Biotechnol 2012;94:495-503.
24. Kobayashi A, Kirschvink J, Nash CZ, Kopp RE, Sauer DA, Bertani LE, et al. Experimental observation of magnetosome chain collapse in magnetotactic bacteria: Sedimentological paleomagnetic, and evolutionary implications. Earth Planet Sci Lett 2006; 245:538-50.
25. Grünberg K, Wawer C, Tebo BM, Schüler D. A large gene cluster encoding several magnetosome proteins is conserved in different species of magnetotactic bacteria. Appl Environ Microbiol 2001; 67:4573-82. (Pubitemid 33646086)
26. Sun J-B, Duan J-H, Dai S-L, Ren J, Zhang Y-D, Tian J-S, Li Y. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: The magnetic bionanoparticles as drug carriers. Cancer Lett 2007;258:109-17. (Pubitemid 47610803)
27. Gorby YA, Beveridge TJ, Blakemore RP. Characterization of the bacterial magnetosome membrane. J Bacteriol 1988;170:834-41.
28. Alphandéry E, Ngo AT, Lefèvre C, Lisiecki I, Wu LF, Pileni MP. Difference between the magnetic properties of the magnetotactic bacteria and those of the extracted chains of magnetosomes: Influence of the distance between the chains of magnetosomes. J Phys Chem C 2008;112:12304-9.
29. Sun J, Tang T, Duan J, Xu P-X, Wang Z, Zhang Y, et al. Biocompatibility of bacterial magnetosomes: Acute toxicity, immunotoxicity and cytotoxicity. Nanotoxicology 2010;4:271-83.
30. Alphandéry E, Carvollo C, Menguy N, Chebbi I. Chains of cobalt doped magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. J Phys Chem C 2011;115:11920-4.
31. Guo FF, Yang W, Jiang W, Geng S, Peng T, Li JL. Magnetosomes eliminate intracellular reactive oxygen species in Magnetospirillum gryphiswaledense MSR-1. Environ Microbiol 2012;14:1722-9.
32. Liu R-T, Liu J, Tong J-Q, Tang T, Kong W-C, Wang X-W, et al. Heating effect and biocompatibility of bacterial magnetosomes as potential materials used in magnetic fluid hyperthermia. Prog Nat Sci Mater Int 2012;22:31-9.
33. Sun J-B, Wang Z-L, Duan J-H, Ren J, Yang X-D, Dai S-L, et al. Targeted distribution of bacterial magnetosomes isolated from Magnetospirillum gryphiswaldense MSR-1 in healthy Sprague-Dawley rats. J Nanosci Nanotechnol 2009;9:1881-5.
34. Lacava LM, Garcia VAP, Kückelhaus S, Azevedo RB, Sadeghiani N, Buske N, et al. Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen. J Magn Magn Mater 2004; 272:2434-5. (Pubitemid 41066985)
35. Timko M, Dzarova A, Skumiel A, Jozefcak A, Hornowski T, Gojzewski H, et al. Magnetic properties and heating effect in bacterial magnetic nanoparticles. J Magn Magn Mater 2009;321: 1521-4.
36. Timko M, Molcan M, Hashim A, Skumiel A, Muller M, Gojzewski H, et al. Hyperthermic effect in suspension of magnetosomes prepared by various methods. IEE Trans Magn 2013;49:250-4.
37. Hergt R, Dutz S, Roder M. Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J Phys Condens Matter 2008;20:385214-25.
38. Hergt R, Hiergeist R, Zeisberger M, Schüler D, Heyen U, Hilger I, et al. Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools. J Magn Magn Mater 2005;293: 80-6. (Pubitemid 40608913)
39. Dutz S, Hergt R, Mürbe J, Müller R, Zeisberger M, Andrä W, et al. Hysteresis losses of magnetic nanoparticle powders in the single domain size range. J Magn Magn Mater 2007;308:305-12. (Pubitemid 44548170)
40. Alphandéry E, Faure S, Raison L, Duguet E, Howse PA, Bazylinski DA. Heat production by bacterial magnetosomes exposed to an oscillating magnetic field. J Phys Chem C 2011;115:18-22.
41. Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J Magn Magn Mater 2002;252:370-4.
42. Scheffel A, Gruska M, Faivre D, Linaroudis A, Grumann P, Plitzko JM, et al. An acidic protein aligns magnetosomes along a filamentous structure in magnetotactic bacteria. Nature 2006;440: 110-14. (Pubitemid 43336277)
43. Alphandéry E, Chebbi I, Faure S. Treatment of cancer or tumor induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternative magnetic field. Patent WO2011/061259. First submission Nov 2009.
44. Alphandéry E, Ding Y, Ngo AT, Wang ZL, Wu LF, Pileni MP. Assemblies of aligned magnetotactic bacteria and extracted magnetosomes: What is the main factor responsible for the magnetic anisotropy? ACS Nano 2009;3:1539-47.